Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
MEP47608A - Controlled release oxycodone compositions - Google Patents
[go: Go Back, main page]

MEP47608A - Controlled release oxycodone compositions - Google Patents

Controlled release oxycodone compositions

Info

Publication number
MEP47608A
MEP47608A MEP-476/08A MEP47608A MEP47608A ME P47608 A MEP47608 A ME P47608A ME P47608 A MEP47608 A ME P47608A ME P47608 A MEP47608 A ME P47608A
Authority
ME
Montenegro
Prior art keywords
dosage form
controlled release
hours
oxycodone
oxycodone released
Prior art date
Application number
MEP-476/08A
Other languages
Bosnian (bs)
English (en)
Croatian (hr)
Inventor
Benjamin Oshlack
Mark Chasin
John Joseph Minogue
Robert Francis Kaiko
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of MEP47608A publication Critical patent/MEP47608A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5015Organic compounds, e.g. fats, sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MEP-476/08A 1992-11-25 1993-05-21 Controlled release oxycodone compositions MEP47608A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1014692A 1992-11-25 1992-11-25

Publications (1)

Publication Number Publication Date
MEP47608A true MEP47608A (en) 2011-02-10

Family

ID=37616752

Family Applications (6)

Application Number Title Priority Date Filing Date
MEP-476/08A MEP47608A (en) 1992-11-25 1993-05-21 Controlled release oxycodone compositions
MEP-475/08A MEP47508A (en) 1992-11-25 1993-05-21 Controlled release oxycodone compositions
MEP-477/08A MEP47708A (en) 1992-11-25 1993-05-21 Controlled release oxycodone compositions
MEP-478/08A MEP47808A (en) 1992-11-25 1993-05-21 Controlled release oxycodone compositions
MEP-480/08A MEP48008A (en) 1992-11-25 1993-05-21 Controlled release oxycodone compositions
MEP-479/08A MEP47908A (en) 1992-11-25 1993-05-21 Controlled release oxycodone compositions

Family Applications After (5)

Application Number Title Priority Date Filing Date
MEP-475/08A MEP47508A (en) 1992-11-25 1993-05-21 Controlled release oxycodone compositions
MEP-477/08A MEP47708A (en) 1992-11-25 1993-05-21 Controlled release oxycodone compositions
MEP-478/08A MEP47808A (en) 1992-11-25 1993-05-21 Controlled release oxycodone compositions
MEP-480/08A MEP48008A (en) 1992-11-25 1993-05-21 Controlled release oxycodone compositions
MEP-479/08A MEP47908A (en) 1992-11-25 1993-05-21 Controlled release oxycodone compositions

Country Status (2)

Country Link
ME (6) MEP47608A (sr)
RS (2) RS50058B (sr)

Also Published As

Publication number Publication date
RS50057B (sr) 2008-11-28
MEP47508A (en) 2011-02-10
MEP48008A (en) 2011-02-10
MEP47908A (en) 2011-02-10
YU20050413A (sh) 2006-08-17
MEP47708A (en) 2011-02-10
YU20050411A (sh) 2006-08-17
RS50058B (sr) 2008-11-28
MEP47808A (en) 2011-02-10

Similar Documents

Publication Publication Date Title
YU35893A (sh) Formulacije oksidona sa kontrolisanim otpuštanjem i njihova upotreba
ES2058111T3 (es) Composicion de liberacion controlada de dihidrocodeina.
GB2196848B (en) Controlled release hydromorphone composition
RU2005115855A (ru) Композиция трамадола продлонгированного высвобождением с 24-часовым действием
BE901359A (fr) Composition pharmaceutique a absorption reglee.
GR3036253T3 (en) Cyclopropyl alkanoic acid derivatives
NO973646D0 (no) Orale doseringsformer inneholdende et <beta>-laktam antibiotikum
MEP47608A (en) Controlled release oxycodone compositions
PT1121109E (pt) Formulacao bifasica contendo tramadol
YU20050410A (sh) Kompozicije oksikodona sa kontrolisanim oslobađanjem
FR2477015B1 (sr)
ATE192749T1 (de) Wässrige spectinomycinborat-auflösung
ATE77238T1 (de) Primycin-loesungen.
GB1345358A (en) Antiinflammatory preparations
GT197640950A (es) Composiciones de oxitetraciclina y su preparacion.
GB1527660A (en) Agents for combating bilharziosis